Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 206843 / DOSAGE - TABLET;ORAL - EQ 60MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DACLATASVIR DIHYDROCHLORIDE(UNII: 50ZO25C11D) (DACLATASVIR - UNII:LI2427F9CI) | DACLATASVIR | 30mg | 60mg | 90mg |
Inactive Ingredients
| Ingredient Name | E.R. Squibb & Sons, L.L.C. |
|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |
| ANHYDROUS LACTOSE(3SY5LH9PMK) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| INDIGOTINDISULFONATE SODIUM(D3741U8K7L) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POLYETHYLENE GLYCOL 400(B697894SGQ) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?
